5TX Stock Overview A medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Sensus Healthcare, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Sensus Healthcare Historical stock prices Current Share Price US$6.80 52 Week High US$8.60 52 Week Low US$2.14 Beta 1.18 1 Month Change -19.05% 3 Month Change 38.21% 1 Year Change 198.25% 3 Year Change -6.85% 5 Year Change n/a Change since IPO 198.77%
Recent News & Updates
Third quarter 2024 earnings released: EPS: US$0.074 (vs US$0.089 loss in 3Q 2023) Nov 17
Investor sentiment improves as stock rises 16% Nov 16
Investor sentiment deteriorates as stock falls 15% Sep 09
Second quarter 2024 earnings released: EPS: US$0.099 (vs US$0.023 loss in 2Q 2023) Aug 09
Investor sentiment improves as stock rises 15% Jul 16
Independent Director recently sold €114k worth of stock May 26 See more updates
Third quarter 2024 earnings released: EPS: US$0.074 (vs US$0.089 loss in 3Q 2023) Nov 17
Investor sentiment improves as stock rises 16% Nov 16
Investor sentiment deteriorates as stock falls 15% Sep 09
Second quarter 2024 earnings released: EPS: US$0.099 (vs US$0.023 loss in 2Q 2023) Aug 09
Investor sentiment improves as stock rises 15% Jul 16
Independent Director recently sold €114k worth of stock May 26
Investor sentiment improves as stock rises 38% May 16
First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.12 loss in 1Q 2023) May 12
Sensus Healthcare, Inc., Annual General Meeting, May 31, 2024 May 01
Full year 2023 earnings released: EPS: US$0.03 (vs US$1.47 in FY 2022) Mar 19
Full year 2023 earnings released: EPS: US$0.03 (vs US$1.47 in FY 2022) Feb 11
Sensus Healthcare Announces Directors Changes Feb 02
New major risk - Share price stability Jan 24
Sensus Healthcare, Inc. to Report Q4, 2023 Results on Feb 08, 2024 Jan 24
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023 Jan 23
Sensus Healthcare, Inc. Appoints Michael Sardano as A Director, Effective February 1, 2024 Jan 19
Third quarter 2023 earnings released: US$0.089 loss per share (vs US$0.11 profit in 3Q 2022) Nov 12
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego Sep 27
New major risk - Earnings quality Aug 14
Investor sentiment improves as stock rises 36% Aug 10 Sensus Healthcare, Inc. (NasdaqCM:SRTS) announces an Equity Buyback for $3 million worth of its shares. Aug 09
Second quarter 2023 earnings released: US$0.023 loss per share (vs US$0.21 profit in 2Q 2022) Aug 06
Investor sentiment improves as stock rises 18% Jul 03
Investor sentiment improves as stock rises 15% Jun 08
Independent Director recently bought €55k worth of stock May 11
Investor sentiment deteriorates as stock falls 36% May 10
First quarter 2023 earnings released: US$0.12 loss per share (vs US$0.97 profit in 1Q 2022) May 05
Full year 2022 earnings released: EPS: US$1.47 (vs US$0.25 in FY 2021) Mar 27
Investor sentiment deteriorates as stock falls 16% Mar 08
Now 21% undervalued Feb 23
Investor sentiment deteriorates as stock falls 18% Feb 16
Full year 2022 earnings released: EPS: US$1.47 (vs US$0.25 in FY 2021) Feb 11
Sensus Healthcare, Inc. Announces Senior Management Appointments and Promotions Jan 10
Investor sentiment improved over the past week Jan 10
Sensus Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2022 Jan 07 Sensus Healthcare, Inc. to Report Q4, 2022 Results on Feb 09, 2023
Insufficient new directors Nov 16
Third quarter 2022 earnings released: EPS: US$0.11 (vs US$0.012 in 3Q 2021) Nov 05
Investor sentiment deteriorated over the past week Nov 04
Sensus Healthcare, Inc. Introduces Silk(TM) Laser Hair Removal System Oct 21
Co-Founder recently sold €524k worth of stock Sep 08
Sensus Healthcare, Inc. Appoints Mohammad K. Khan to Medical Advisory Board Sep 08
Investor sentiment improved over the past week Aug 11
Independent Director recently sold €686k worth of stock Aug 11
Sensus Healthcare, Inc. Launches Upgrade to its SRT-100 Vision System with New Ultrasound Capabilities Aug 10
Second quarter 2022 earnings released: EPS: US$0.21 (vs US$0.017 loss in 2Q 2021) Aug 06
Investor sentiment improved over the past week Jul 08
Independent Director recently sold €72k worth of stock May 13
First quarter 2022 earnings released: EPS: US$0.97 (vs US$0.068 loss in 1Q 2021) May 07
Insufficient new directors Apr 27
Full year 2021 earnings released: EPS: US$0.25 (vs US$0.42 loss in FY 2020) Mar 29
Investor sentiment improved over the past week Mar 22
Co-Founder recently sold €1.2m worth of stock Mar 12
Empyrean Medical System Inc. acquired Sculptura Assets of Sensus Healthcare, Inc. for $15 million. Mar 04
Investor sentiment improved over the past week Feb 17
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 11
Sensus Healthcare, Inc. Announces Three Promotions Feb 03
Sensus Healthcare, Inc. Announces Executive Changes Feb 01
Now 20% undervalued Jan 19 Sensus Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2021
Forecast breakeven date moved forward to 2021 Dec 03
Sensus Healthcare, Inc. Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia Dec 02
Third quarter 2021 earnings released: EPS US$0.012 (vs US$0.10 loss in 3Q 2020) Nov 06
Forecast to breakeven in 2022 Sep 23
Second quarter 2021 earnings released: US$0.017 loss per share (vs US$0.16 loss in 2Q 2020) Aug 09
First quarter 2021 earnings released: US$0.068 loss per share (vs US$0.22 loss in 1Q 2020) May 09
Colorado State University, Flint Animal Cancer Center Applies Sensus Healthcare’s SRT Non-Surgical Treatment to Animal Care Mar 17
Full year 2020 earnings released: US$0.42 loss per share (vs US$0.10 loss in FY 2019) Feb 27
Revenue beats expectations Feb 27
New 90-day high: €3.55 Feb 27
New 90-day high: €3.53 Jan 09
New 90-day high: €3.02 Dec 18
Sensus Healthcare, Inc. Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems Dec 17
Sensus Healthcare, Inc. Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision Dec 03
Third quarter 2020 earnings released: US$0.10 loss per share Nov 16
Revenue misses expectations Nov 16
Revenue misses expectations Nov 07
Third quarter 2020 earnings released: US$0.10 loss per share Nov 07
Sensus Healthcare, Inc. Appoints Megan Cornish to Its Board of Directors Nov 06 Shareholder Returns 5TX DE Medical Equipment DE Market 7D -11.1% -3.3% -2.0% 1Y 198.2% -8.5% 6.9%
See full shareholder returns
Return vs Market: 5TX exceeded the German Market which returned 6.9% over the past year.
Price Volatility Is 5TX's price volatile compared to industry and market? 5TX volatility 5TX Average Weekly Movement 7.3% Medical Equipment Industry Average Movement 6.7% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 5TX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5TX's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Show more Sensus Healthcare, Inc. Fundamentals Summary How do Sensus Healthcare's earnings and revenue compare to its market cap? 5TX fundamental statistics Market cap €111.53m Earnings (TTM ) €8.92m Revenue (TTM ) €39.59m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 5TX income statement (TTM ) Revenue US$41.31m Cost of Revenue US$16.15m Gross Profit US$25.16m Other Expenses US$15.85m Earnings US$9.31m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 05:15 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Sensus Healthcare, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Andrew D'Silva B. Riley Securities, Inc. Alexander Nowak Craig-Hallum Capital Group LLC Ilya Zubkov Freedom Broker
Show 5 more analysts 
